F Berthezène

952 total citations
49 papers, 749 citations indexed

About

F Berthezène is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, F Berthezène has authored 49 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in F Berthezène's work include Thyroid Disorders and Treatments (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). F Berthezène is often cited by papers focused on Thyroid Disorders and Treatments (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). F Berthezène collaborates with scholars based in France, United States and Denmark. F Berthezène's co-authors include Gabriel Ponsin, Sophie Bernard, Giatgen A. Spinas, Henning Beck‐Nielsen, Michele Muggeo, Sudhesh Kumar, A. J. M. Boulton, Bertil Persson, Stephen Donoghue and Sandrine Touzet and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, European Heart Journal and Diabetologia.

In The Last Decade

F Berthezène

46 papers receiving 698 citations

Peers

F Berthezène
M. Miola Italy
Isabel Beucler France
Sheng Jiao China
Liliane K. Yacoub United States
D. J. Galton United Kingdom
Daniel Brun Canada
Haruo UZAWA Japan
A Raisonnier France
T W de Bruin Netherlands
A.C. Nestruck Canada
M. Miola Italy
F Berthezène
Citations per year, relative to F Berthezène F Berthezène (= 1×) peers M. Miola

Countries citing papers authored by F Berthezène

Since Specialization
Citations

This map shows the geographic impact of F Berthezène's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Berthezène with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Berthezène more than expected).

Fields of papers citing papers by F Berthezène

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Berthezène. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Berthezène. The network helps show where F Berthezène may publish in the future.

Co-authorship network of co-authors of F Berthezène

This figure shows the co-authorship network connecting the top 25 collaborators of F Berthezène. A scholar is included among the top collaborators of F Berthezène based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Berthezène. F Berthezène is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marçais, Christophe, et al.. (2000). Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency. Diabetologia. 43(11). 1346–1352. 25 indexed citations
2.
Krempf, Michel, et al.. (1997). Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.. PubMed. 23(2). 131–6. 5 indexed citations
3.
Elchebly, Mounib, et al.. (1996). Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non‐insulin‐dependent diabetes. European Journal of Clinical Investigation. 26(3). 216–223. 15 indexed citations
4.
Kumar, Sudhesh, A. J. M. Boulton, Henning Beck‐Nielsen, et al.. (1996). Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia. 39(6). 701–709. 194 indexed citations
5.
6.
Ponsin, Gabriel, et al.. (1994). Mechanism of the Gemfibrozil-Induced Decrease in the Transfer of Cholesterol Esters from High Density Lipoproteins to Very Low and Low Density Lipoproteins. Biochemical Medicine and Metabolic Biology. 52(1). 58–64. 11 indexed citations
7.
8.
Berthezène, F, et al.. (1993). Decreased ability of high density lipoproteins to transfer cholesterol esters in non‐insulin‐dependent diabetes mellitus. European Journal of Clinical Investigation. 23(8). 459–465. 24 indexed citations
9.
Trouillas, Jacqueline, G. Sassolas, B Loras, et al.. (1991). Somatotrpic Adenomas without Acromegaly. Pathology - Research and Practice. 187(8). 943–949. 34 indexed citations
10.
Dusserre, Eric, et al.. (1991). [Modulation of arterial smooth muscle cells in culture and cholesterol exchange].. PubMed. 52(6). 464–6. 2 indexed citations
11.
Ponsin, Gabriel, et al.. (1990). Alterations of High Density Lipoproteins Induced by Thyroid Hormones in Man and Rat. Advances in experimental medicine and biology. 285. 147–154. 2 indexed citations
12.
Calvo, Carlos, Gabriel Ponsin, & F Berthezène. (1988). Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients.. PubMed. 14(3). 264–9. 28 indexed citations
13.
Orgiazzi, Jacques, et al.. (1987). High Voltage Orbital Radiotherapy and Surgical Orbital Decompression in the Management of Graves’ Ophthalmopathy. Hormone Research. 26(1-4). 172–176. 17 indexed citations
14.
15.
Laville, Martine, J. P. Riou, Pierre Bougnères, et al.. (1984). Glucose Metabolism in Experimental Hyperthyroidism: Intactin VivoSensitivity to Insulin with Abnormal Binding and Increased Glucose Turnover. The Journal of Clinical Endocrinology & Metabolism. 58(6). 960–965. 51 indexed citations
16.
Beylot, M., et al.. (1983). [Measurement of insulin sensitivity using the somatostatin-insulin-glucose test. Importance of the determination of plasma free fatty acids and insulin clearance].. PubMed. 12(40). 2517–20. 1 indexed citations
17.
Mornex, R, et al.. (1981). [Surgical treatment of Graves' disease (author's transl)].. PubMed. 41(6). 614–7. 3 indexed citations
18.
Berthezène, F, et al.. (1975). [Proceedings: Pituitary thyroid axis in subacute thyroiditis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(3). 169–70. 1 indexed citations
19.
Berthezène, F, et al.. (1974). Increase in the Amount of Iodide Released from the Thyroid after Perchlorate or Carbimazole Administration. Hormone and Metabolic Research. 6(4). 306–308. 2 indexed citations
20.
Mornex, R & F Berthezène. (1970). Comments on a Proposed New Way of Measuring Thyrotropin (TSH) Reserve. The Journal of Clinical Endocrinology & Metabolism. 31(5). 587–589. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Miola Breakdown of academic impact, for papers by Isabel Beucler Breakdown of academic impact, for papers by Sheng Jiao Breakdown of academic impact, for papers by Liliane K. Yacoub Breakdown of academic impact, for papers by D. J. Galton Breakdown of academic impact, for papers by Daniel Brun Breakdown of academic impact, for papers by Haruo UZAWA Breakdown of academic impact, for papers by A Raisonnier Breakdown of academic impact, for papers by T W de Bruin Breakdown of academic impact, for papers by A.C. Nestruck
Rankless by CCL
2026